05/06/2026
Australian health and medtech innovation has enormous potential. But potential alone doesn't scale.
It takes connected systems — aligned capital, specialist expertise, trusted networks and leaders who know how to navigate complexity.
That's what makes HESTA's anchor investment in Synthesis Capital so significant. It's not just a capital story. It's a systems story.
Synthesis Capital brings together capital, venture-building capability and global networks to help high-potential companies move from breakthrough science to real-world impact. For us at Menzies Leadership Foundation, it reflects something we've believed for a long time: innovation doesn't scale through individual brilliance alone. It scales when the conditions around it are right.
Since 2018, through our partnership with MedTech Actuator, we've been helping researchers, clinicians and founders build the capability, confidence and connections to move ideas forward. Synthesis Capital is a powerful next step in that journey.
As our CEO Liz Gillies put it: "This is systems entrepreneurship in action. It shows what becomes possible when catalytic capital, capability and connectivity are brought together around a shared purpose."
We've shared our full thinking on what this announcement means — for Australian health innovation, for ecosystem-building, and for the role philanthropy can play in helping systems shift.
👉 Read our response https://menziesfoundation.org.au/mobilising-capital-to-help-australian-health-innovation-scale/ — and follow the AFR's coverage of HESTA's $70m investment to see the broader picture.
If this kind of work matters to you, we'd love to have you in the conversation.